SCRS Sites Directory

Search SCRS member sites. Discover current trials.

Healthcare Research Network - Chicago

Phase II & Phase III Clinical Research - Focusing in Prevalent Chronic Conditions

Healthcare Research Network - Chicago

Healthcare Research Network - St. Louis is an elite Clinical Research Site Network comprised of private physicians from multiple specialties that conduct clinical research studies.  Our focus is in Phase IIB – Phase IV clinical research.  Our concentration is in prevalent chronic conditions.  We were founded in 1998 and have successfully completed over 1000 trials.  Our randomization to contractual commitment ration is 108% over the last 5 years. 

Our therapeutic focus and research experience includes the following: 
• Chronic Pain
• Osteoarthritis 
• Rheumatology (RA, Gout)
• Endocrinology (Diabetes and Metabolic Disorders)
• Asthma/Allergy
• Pulmonary Diseases
• Gastrointestinal (IBS, Ulcerative Colitis, Crohn's Disease)
• Oncology
• Hematology
• Neurological Disorders
• Psychiatry

Study Search 


Demographic Data

  • Start year clinical research1998
  • Phases of clinical studiesPhase II, Phase III, Phase IV
  • Types of studiesBiologics, Drugs, Medical Devices, Nutraceuticals, Vaccines
  • PopulationsAdult 18-64 yrs, Senior 65 yrs and over
  • Type of siteFreestanding
  • # of employees involved in research4
  • # of investigators4
  • Days openMonday, Tuesday, Wednesday, Thursday, Friday, Saturday
  • Extended office hoursYes
  • Dry iceYes
  • Blinded pharmacistYes
  • Dedicated monitoring spaceYes
  • Internet access for the monitorYes
  • Onsite laboratoryYes
  • Central laboratoryYes
  • Infusion capabilityYes
  • Shipping optionsFedEx, UPS, DHL, Other
  • Contact for regulatory documentsBrian Springer
  • Regulatory phone number(312) 731-6128
  • # of days to turn around regulatory documents3-5
  • Type of IRB used by this siteCentral
  • Appropriate storage facilities for productYes
  • Able to appropriately store Schedule II drugsYes
  • # days to turn around budget and contract2-3